N6-methyladenosine modification of REG1α facilitates colorectal cancer progression via β-catenin/MYC/LDHA axis mediated glycolytic reprogramming
Mingxia Zhou(First Affiliated Hospital of Zhengzhou University), Hongtao Wen(First Affiliated Hospital of Zhengzhou University), Xuexin Wang(First Affiliated Hospital of Zhengzhou University), Dan Du(Sichuan University), Hongle Li(Shanghai Jiao Tong University), Chenxi Ju(First Affiliated Hospital of Zhengzhou University), Yingxia Li(Henan University of Traditional Chinese Medicine), Chang Wang(First Affiliated Hospital of Zhengzhou University), Libin Jiang(Henan University of Urban Construction), Jing He(First Affiliated Hospital of Zhengzhou University), Fucheng He(First Affiliated Hospital of Zhengzhou University), Jiaxuan Ran(First Affiliated Hospital of Zhengzhou University), Xinyu Xu(Wuxi No.2 People's Hospital)
Cited by 38
Related Papers
MEK inhibitors for the treatment of non-small cell lung cancer
|Journal of Hematology & Oncology|2021|300
Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
|Journal of Experimental & Clinical Cancer Research|2016|86
LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis
|Biomedicine & Pharmacotherapy|2019|72
Tetramethylpyrazine inhibits CoCl<sub>2</sub>‐induced neurotoxicity through enhancement of Nrf2/GCLc/GSH and suppression of HIF1α/NOX2/ROS pathways
|Journal of Neurochemistry|2015|66
IGF2BP2-induced circRUNX1 facilitates the growth and metastasis of esophageal squamous cell carcinoma through miR-449b-5p/FOXP3 axis
|Journal of Experimental & Clinical Cancer Research|2022|64